Initial safety assessment of the endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer: NRG-GI007.Geoffrey Y. Ku, Theodore S. Hong, Makoto Nishimura et al.|Journal of Clinical Oncology|2024Cited by 1
NRG-GI007: Secondary endpoints of safety assessment and clinical complete response (cCR) of chemoradiation with endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer.Geoffrey Y. Ku, Theodore S. Hong, Jennifer Moughan et al.|Journal of Clinical Oncology|2025Cited by 0